BARINGS CORPORATE INVESTORS Business Summary

Barings Corporate Investors (MCI) is a closed-end management investment company that generates revenue primarily through interest income and capital gains derived from a specialized portfolio of privately placed, below-investment-grade corporate debt. The Trust’s business model focuses on the middle-market U.S. segment, sourcing long-term debt obligations—such as senior loans and mezzanine debt—often enhanced with equity features like warrants or conversion rights to capture upside potential. Its primary business segments are divided between private placement securities, which constitute the core of its long-term strategy, and a secondary allocation of marketable investment-grade debt and common stocks used for liquidity and tactical positioning. Within the competitive landscape, MCI contends with peers such as BlackRock Capital Allocation Term Trust (BCAT), Goldman Sachs BDC (GSBD), and Central Securities (CET), distinguishing itself as a high-yield income vehicle with a 50-year track record in the private credit niche. Originally launched in 1971 as Babson Capital Corporate Investors, the Trust is currently led by President Christina Emery, a seasoned Managing Director at Barings with over two decades of experience in private credit and a pedigree that includes investment banking at Legg Mason and an MBA from the University of Virginia’s Darden School. Chairman Clifford M. Noreen provides strategic oversight, leveraging a 35-year career that includes serving as Head of Global Investment Strategy at MassMutual. The executive team is further supported by CFO Christopher Hanscom and Chief Legal Officer Ashlee Steinnerd. As a subsidiary-managed entity of MassMutual, the Trust benefits from a robust governance structure featuring notable board members such as Lead Independent Trustee Maleyne Syracuse and Audit Chair Barbara Ginader, ensuring alignment with institutional-grade risk management standards.